Table 1.

Clinical Evaluation of the 20 Patients With Schizophrenia

	CPZ (mg/d)	PANSS					BPRS [24–168]	NSS
		Total score [30–210]	Positive subscore [7–49]	Negative subscore [7–49]	General subscore [16–112]	Disorganization subscore [4–28]		Total score [0–105]	Sensory integration subscore [0–15]	Motor coordination subscore [0–21]	Motor integration subscore [0–18]
1	80	63	10	15	38	7	48	1.5	0	0.5	0
2	35	54	13	11	30	10	46	18.5	0.5	9	2
3	200	63	12	16	35	7	52	12.5	0.5	6.5	0
4	200	56	9	14	33	12	40	13	4.5	5.5	2
5	300	44	9	12	23	6	37	6	0.5	3.5	0
6	267	50	13	17	20	7	44	18.5	3.5	7	1
7	75	44	9	9	26	6	36	5.5	0	3.5	0
8	200	52	10	13	29	4	44	9	1	7	0
9	200	63	9	21	33	6	45	7.5	1	4	1
10	200	56	9	11	36	9	41	18	0.5	7.5	1.5
11	300	81	14	28	39	11	49	19.5	2	7.5	3
12	300	51	14	13	24	11	42	21	5.5	6	4
13	200	44	7	11	26	7	36	16.5	1	7	0
14	300	47	10	11	26	10	40	17.5	4	8	1
15	100	54	8	10	36	4	46	3	0	3	0
16	1067	61	10	17	34	9	48	14.5	2.5	5.5	2
17	67	52	19	10	23	4	44	21	4	1.5	1
18	267	64	14	14	36	8	64	13.5	2	4	0.5
19	250	57	21	9	27	9	45	11.5	4	3.5	0
20	1067	59	12	10	37	9	38	16	2	8.5	1.5
Mean ± SD	284 ± 281	56 ± 9	12 ± 4	14 ± 5	31 ± 6	8 ± 2	44 ± 6	13.2 ± 6.1	2 ± 1.7	5.4 ± 2.4	1 ± 1.1

Note: CPZ, chlorpromazine equivalent; PANSS, Positive and Negative Syndrome Scale; BPRS, Brief Psychiatric Rating Scale; NSS, neurological soft signs; PSZ, patients with schizophrenia. Individual CPZ and scores for PANSS, BPRS, and NSS for the group of PSZ. In brackets: min–max score of the respective scale.